A detailed history of Legal & General Group PLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Legal & General Group PLC holds 146,468 shares of JAZZ stock, worth $17.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
146,468
Previous 146,468 -0.0%
Holding current value
$17.8 Million
Previous $16.3 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.57 - $116.37 $11.5 Million - $13.4 Million
-114,808 Reduced 43.94%
146,468 $16.3 Million
Q2 2024

Aug 14, 2024

SELL
$103.94 - $118.98 $19.1 Million - $21.8 Million
-183,543 Reduced 41.26%
261,276 $27.9 Million
Q1 2024

May 14, 2024

SELL
$115.19 - $132.77 $3.43 Million - $3.95 Million
-29,784 Reduced 6.28%
444,819 $53.6 Million
Q4 2023

Feb 15, 2024

BUY
$114.26 - $136.0 $7.23 Million - $8.6 Million
63,255 Added 15.38%
474,603 $58.4 Million
Q3 2023

Nov 14, 2023

SELL
$122.0 - $145.31 $3.27 Million - $3.9 Million
-26,838 Reduced 6.12%
411,348 $53.2 Million
Q2 2023

Aug 14, 2023

SELL
$122.5 - $147.16 $3.52 Million - $4.23 Million
-28,759 Reduced 6.16%
438,186 $54.3 Million
Q1 2023

May 15, 2023

SELL
$133.98 - $160.47 $1.85 Million - $2.21 Million
-13,783 Reduced 2.87%
466,945 $68.3 Million
Q4 2022

Feb 14, 2023

SELL
$129.72 - $159.85 $1.31 Million - $1.62 Million
-10,117 Reduced 2.06%
480,728 $76.6 Million
Q3 2022

Nov 14, 2022

SELL
$126.59 - $161.18 $217,481 - $276,907
-1,718 Reduced 0.35%
490,845 $65.4 Million
Q2 2022

Aug 22, 2022

SELL
$141.59 - $168.66 $149,660 - $178,273
-1,057 Reduced 0.21%
492,563 $76.8 Million
Q1 2022

May 16, 2022

BUY
$129.64 - $160.7 $5.88 Million - $7.29 Million
45,373 Added 10.12%
493,620 $76.8 Million
Q4 2021

Feb 14, 2022

SELL
$119.87 - $145.67 $734,803 - $892,957
-6,130 Reduced 1.35%
448,247 $57.1 Million
Q3 2021

Nov 15, 2021

SELL
$128.64 - $184.79 $2.81 Million - $4.04 Million
-21,837 Reduced 4.59%
454,377 $59.2 Million
Q2 2021

Aug 12, 2021

BUY
$160.2 - $186.42 $6.11 Million - $7.11 Million
38,163 Added 8.71%
476,214 $84.6 Million
Q1 2021

May 17, 2021

SELL
$150.19 - $173.5 $1.01 Million - $1.16 Million
-6,698 Reduced 1.51%
438,051 $72 Million
Q4 2020

Feb 12, 2021

SELL
$140.71 - $165.05 $838,772 - $983,863
-5,961 Reduced 1.32%
444,749 $73.4 Million
Q3 2020

Nov 13, 2020

BUY
$105.46 - $144.13 $5.51 Million - $7.52 Million
52,203 Added 13.1%
450,710 $64.3 Million
Q2 2020

Aug 14, 2020

BUY
$95.68 - $121.88 $4.36 Million - $5.55 Million
45,572 Added 12.91%
398,507 $44 Million
Q1 2020

May 14, 2020

BUY
$87.74 - $152.74 $745,351 - $1.3 Million
8,495 Added 2.47%
352,935 $35.3 Million
Q4 2019

Feb 13, 2020

BUY
$117.65 - $153.73 $1.23 Million - $1.61 Million
10,480 Added 3.14%
344,440 $51.4 Million
Q3 2019

Nov 13, 2019

BUY
$125.18 - $143.24 $663,579 - $759,315
5,301 Added 1.61%
333,960 $42.8 Million
Q2 2019

Aug 14, 2019

SELL
$125.55 - $144.48 $772,509 - $888,985
-6,153 Reduced 1.84%
328,659 $46.9 Million
Q1 2019

May 15, 2019

BUY
$121.81 - $142.95 $8.87 Million - $10.4 Million
72,784 Added 27.78%
334,812 $47.9 Million
Q4 2018

Feb 15, 2019

BUY
$115.94 - $166.74 $2.35 Million - $3.38 Million
20,277 Added 8.39%
262,028 $32.5 Million
Q3 2018

Nov 20, 2018

BUY
$161.01 - $180.57 $73,420 - $82,339
456 Added 0.19%
241,751 $40.6 Million
Q2 2018

Aug 10, 2018

BUY
$146.33 - $183.18 $624,536 - $781,812
4,268 Added 1.8%
241,295 $41.6 Million
Q1 2018

May 17, 2018

SELL
$135.59 - $157.16 $18,847 - $21,845
-139 Reduced 0.06%
237,027 $35.8 Million
Q4 2017

Feb 13, 2018

BUY
$131.06 - $150.39 $31.1 Million - $35.7 Million
237,166
237,166 $31.9 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.63B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.